Monitoring therapy for central precocious puberty [2] (multiple letters)

Pediatrics

Volumn 110, Issue 6 I, 2002, Pages 1255-

  Salerno, Mariacarolina ^a   Di Maio, Salvatore ^b   Tenore, Alfred ^c   Neely, E Kirk ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ESTRADIOL; GONADORELIN; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; LONG ACTING DRUG; LUTEINIZING HORMONE; TRIPTORELIN;

CLINICAL PRACTICE; COST; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG MONITORING; ESTRADIOL BLOOD LEVEL; FOLLOW UP; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS GONAD SYSTEM; IMMUNOASSAY; INJECTION; INTERMETHOD COMPARISON; LABORATORY TEST; LETTER; MENARCHE; MENSTRUAL CYCLE; METHODOLOGY; OVARY POLYCYSTIC DISEASE; PARAMETER; PATIENT MONITORING; PEDIATRICS; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RELIABILITY; TREATMENT OUTCOME;

ADOLESCENT; BODY HEIGHT; CHILD; FEMALE; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; HUMANS; MONITORING, PHYSIOLOGIC; PUBERTY, PRECOCIOUS;

EID: 18744375147     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.6.1255     Document Type: Letter

References (0)